Farmacéutica Hispanoamericana
Farmacéutica Hispanoamericana is a private Mexican pharmaceutical laboratory founded in 2004 that manufactures and commercializes 120+ generic medicines across eight therapeutic lines to government, private hospitals, retail pharmacy chains, and consumers in Mexico and Latin America.
- Company typePrivate
- Founded2004
- HeadquartersMiguel Hidalgo, Mexico
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Farmacéutica Hispanoamericana does
Farmacéutica Hispanoamericana is a Mexican pharmaceutical laboratory founded in 2004 by Mexican and Spanish investors that manufactures and commercializes generic medicines across Mexico with exports to Latin America. The company operates through three business units: the core FH brand distributes 120+ products organized across eight therapeutic lines (anti-infectives, anti-inflammatory, gastrointestinal, OTC, respiratory, cardiovascular, women's health, and general medicine); Hosfharma commercializes high-specialty hospital products through an exclusive sales force targeting private hospitals; and Hispanat distributes consumer health, wellness, and beauty products through retail and e-commerce channels.
The company's underlying technology centers on validated pharmaceutical manufacturing processes including injectable lyophilized products, aerosols, nebulization solutions, tablets, capsules, ovules, and topical formulations, supported by an in-house Development Center for new product creation. It maintains a dedicated pharmacovigilance unit for adverse-event monitoring and holds COFEPRIS registrations compliant with Mexican Secretaría de Salud legislation. Manufacturing facilities are located in Mexico City with national distribution infrastructure.
Farmacéutica Hispanoamericana makes money through one-time sales of pharmaceutical products across diversified channels: an enterprise field sales motion via Hosfharma into private hospitals, a direct-to-consumer motion via Hispanat into retail pharmacy chains, e-commerce marketplaces (Amazon, Mercado Libre), and mass retailers (Walmart, Sanborns), distribution through a network of 14+ pharmaceutical wholesalers (Nadro, Reder, Levic, Farmamigo, Brudifarma, FARMA MX, Difarmer, RASE, Vicma, Medicinas del Rosario, Enlace, Lexfarma, Equilibrio Farmacéutico, Disa), and public sector supply via government procurement. Customer segments span government/public sector institutions, private hospitals, retail and consumer channels, and private pharmacies and distributors. Specific pricing is not publicly disclosed.
Farmacéutica Hispanoamericana firmographics
Firmographics- Name
- Farmacéutica Hispanoamericana
- Legal name
- Farmacéutica Hispanoamericana
- Website
- https://fhmex.com.mx
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Farmacéutica Hispanoamericana is a private Mexican pharmaceutical laboratory founded in 2004 that manufactures and commercializes 120+ generic medicines across eight therapeutic lines to government, private hospitals, retail pharmacy chains, and consumers in Mexico and Latin America.
- Ownership category
- akta.pro rank
Farmacéutica Hispanoamericana industry classification
Industry- Product category
- Generic Pharmaceuticals Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic Hospital & Institutional Products (HLAIABAL)
- akta.pro secondary industries
- Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Gastroenterology & Hepatology Pharmaceuticals (HLAIAAAI)
Keywords
Where Farmacéutica Hispanoamericana is headquartered
LocationHeadquarters
- HQ city
- Miguel Hidalgo
- HQ country
- Mexico
- HQ region
- Latin America
Offices1 record
Markets served
Farmacéutica Hispanoamericana business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Product Sales: Manufacturing and commercialization of generic pharmaceutical products through government, private, and retail channels. Products are distributed nationally and exported to Latin America.
- Hospital Product Sales (Hosfharma): High specialty products sold exclusively to private hospitals through dedicated sales force.
- Consumer Health Products (Hispanat): Health, wellness and beauty products commercialized through traditional channels, retailers, e-commerce and marketplaces.
Go-to-market motion2 records
Distribution channels6 records
Marketing channels4 records
Farmacéutica Hispanoamericana product offering
Product offeringCore offering
Farmacéutica Hispanoamericana is a Mexican pharmaceutical laboratory that manufactures and commercializes generic medicines across more than 120 products organized into eight therapeutic lines (anti-infectives, anti-inflammatory, gastrointestinal, OTC/consumer, respiratory, cardiovascular, women's health, and general medicine). The company operates through three business units: the FH main brand for general pharmaceutical products distributed via government, private, and impulse markets; Hosfharma for high-specialty hospital products sold to private hospitals via an exclusive sales force; and Hispanat for health, wellness, and beauty products sold through retail and e-commerce channels.
Product overview
Farmacéutica Hispanoamericana (FH) is a Mexican pharmaceutical laboratory established in 2004 that manufactures and commercializes generic medicines distributed in government, private, and impulse markets across Mexico. The company operates through three main business units: (1) FH brand for general pharmaceutical products, (2) Hosfharma for hospital/pharmacy products targeting private hospitals with high-specialty medications, and (3) Hispanat for health, wellness, and beauty products sold through retail and e-commerce channels. The product portfolio includes more than 120 generic medications across 8 therapeutic lines covering Antiinfectives, Anti-inflammatory, Gastrointestinal, OTC/Consumer, Respiratory, Cardiovascular, Women's Health, and General Medicine. Hosfharma products include hospital-use injectables such as Sevoflurano, Vancomycin, Caspofungin, and Terlipressin. Hispanat offers consumer health supplements like Glutathione and Collagen products.
Differentiator
Problem solved
Functional benefit
Brands
- Hosfharma: Business unit focused on hospital products and high-specialty medications for private hospitals, with exclusive sales force for visit and placement of products.
- Hispanat
Products and services
- Farmacéutica Hispanoamericana (FH) Brand Portfolio
- Hosfharma Hospital Products Unit
- Hispanat Consumer Health Unit
- Respiratory Medications Line
- Anti-infective Antibiotics Line
- Hospital Specialty Injectables (Hosfharma)
- Anti-inflammatory Medications Line
- Gastrointestinal Medications Line
- Cardiovascular Medications Line
- Women's Health Medications Line
- OTC Consumer Healthcare Line
- General Medicine Line
- Hispanat Wellness Supplements
Quantifiable outcome
- 120+ products across 8 therapeutic lines
- +3 more outcomes
Companies that use Farmacéutica Hispanoamericana
Customer profileNamed customers22 records
Segments4 records
Ideal customer profiles4 records
Farmacéutica Hispanoamericana technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Farmacéutica Hispanoamericana partnerships and signals
Strategic signalPartnerships
22 partnerships are on record, tiered core.
- AmazoncoreE-commerce marketplace channel for Hispanat consumer health, wellness and beauty products.
- Mercado LibrecoreE-commerce marketplace channel for Hispanat consumer products in Mexico.
- Farmacias del AhorrocoreMajor retail pharmacy chain distribution channel for pharmaceutical products.
- San PablocoreRetail pharmacy chain channel for pharmaceutical product distribution.
- SanbornscoreRetail pharmacy and store channel for pharmaceutical products.
- WalmartcoreRetail distribution channel for consumer health products through Walmart stores.
- NadrocoreMajor pharmaceutical distributor network in Mexico.
- RedercorePharmaceutical distributor network operating across Mexico.
- DisacorePharmaceutical distribution partner (socio comercial).
- LeviccorePharmaceutical distributor customer.
- FarmamigocorePharmaceutical distributor customer.
- BrudifarmacorePharmaceutical distributor customer.
- FARMA MXcorePharmaceutical distributor customer.
- DifarmercorePharmaceutical distributor customer.
- RASEcorePharmaceutical distributor customer.
- VicmacorePharmaceutical distributor customer.
- Medicinas del RosariocorePharmaceutical distributor customer.
- EnlacecorePharmaceutical distributor customer.
- LexfarmacorePharmaceutical distributor customer.
- Equilibrio FarmacéuticocorePharmaceutical distributor customer.
- KALI ComercializadoracoreHospital and surgical supplies distributor customer for Hosfharma products.
- Oxígeno Medicinal y Accesorios MédicoscoreMedical oxygen and accessories provider, complementary to hospital pharmaceutical supplies.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Farmacéutica Hispanoamericana competitors and assessment
Company assessmentDirect peers
- Laboratorios Sanfer: Major Mexican pharmaceutical company with a broad generic and specialty portfolio across multiple therapeutic categories. Comparable in scale, therapeutic breadth, and multi-channel distribution to FH in the Mexican pharma market.
- Grupo PiSA (Laboratorios PiSA): One of Mexico's largest domestic pharmaceutical manufacturers producing generic injectables, hospital products, and consumer health lines with national distribution. Highly comparable business model to Farmacéutica Hispanoamericana across generic, hospital, and consumer segments.
- Laboratorios Silanes: Mexican pharmaceutical company producing generic and branded medications across multiple therapeutic areas with national distribution. Similar size, therapeutic breadth, and channel strategy to Farmacéutica Hispanoamericana.
- Liomont: Mexican pharmaceutical laboratory manufacturing generic and branded drugs across multiple therapeutic areas with national distribution. Direct competitor in the Mexican generic pharma market with overlapping therapeutic lines and channel mix.
- Carnot Laboratorios: Mexican pharmaceutical manufacturer specializing in generic injectables and hospital products with significant presence in gynecology, anesthesiology, and critical care. Direct competitor to FH's Hosfharma hospital injectables portfolio.
Broad incumbents
- Apotex: One of the largest generic pharmaceutical manufacturers globally with significant Latin American operations including Mexico. Competes with FH in the generic pharma space across multiple therapeutic categories.
- Genomma Lab Internacional: Leading Mexican pharmaceutical company focused on OTC, personal care, and generic pharmaceuticals with extensive retail and pharmacy chain distribution. Comparable in consumer health/pharma retail distribution, though more heavily weighted to OTC brands.
- Sandoz (Novartis) Mexico: Global generic and biosimilar pharmaceutical company with established Mexican operations. Competes with FH in the generic injectables, anti-infectives, and cardiovascular categories in Mexico.
- Teva Pharmaceutical (Mexico): Global generic pharmaceutical leader with a substantial Mexico presence. Competes with FH in generic respiratory, women's health, and other therapeutic categories in the Mexican market.
Regional players
- Asofarma (Mexican operations): Latin American pharmaceutical group (part of the Gador/Asofarma family) with Mexican operations producing generic and specialty pharmaceuticals. Comparable generic pharma business model with regional Latin American footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Farmacéutica Hispanoamericana social profiles
Digital presenceFarmacéutica Hispanoamericana financial estimates
Financial estimateRevenue estimate
Valuation estimate
Farmacéutica Hispanoamericana leadership team
Management profileNumber of profiles
Farmacéutica Hispanoamericana subsidiaries and ownership
Company hierarchySubsidiaries2 records
Farmacéutica Hispanoamericana funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Farmacéutica Hispanoamericana M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Farmacéutica Hispanoamericana
What does Farmacéutica Hispanoamericana do?
Farmacéutica Hispanoamericana is a Mexican pharmaceutical laboratory that manufactures and commercializes generic medicines across more than 120 products organized into eight therapeutic lines (anti-infectives, anti-inflammatory, gastrointestinal, OTC/consumer, respiratory, cardiovascular, women's health, and general medicine). The company operates through three business units: the FH main brand for general pharmaceutical products distributed via government, private, and impulse markets; Hosfharma for high-specialty hospital products sold to private hospitals via an exclusive sales force; and Hispanat for health, wellness, and beauty products sold through retail and e-commerce channels.
Is Farmacéutica Hispanoamericana a public or private company?
Farmacéutica Hispanoamericana is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Farmacéutica Hispanoamericana founded?
Farmacéutica Hispanoamericana was founded in 2004. It employs 101 to 250 people.
Where is Farmacéutica Hispanoamericana based?
Farmacéutica Hispanoamericana is headquartered in Miguel Hidalgo, Mexico, in the Latin America region.
How does Farmacéutica Hispanoamericana make money?
Three revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are hospital Product Sales (Hosfharma) and consumer Health Products (Hispanat).
Who are Farmacéutica Hispanoamericana's main competitors?
Direct peers on record are Laboratorios Sanfer, Grupo PiSA (Laboratorios PiSA), Laboratorios Silanes, Liomont and Carnot Laboratorios. Broad incumbents are Apotex, Genomma Lab Internacional, Sandoz (Novartis) Mexico and Teva Pharmaceutical (Mexico). Asofarma (Mexican operations) is listed as a regional player.
Does Farmacéutica Hispanoamericana have an API?
No public API is recorded for Farmacéutica Hispanoamericana.
What industry is Farmacéutica Hispanoamericana in?
Farmacéutica Hispanoamericana's product category is Generic Pharmaceuticals Manufacturing. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of HLAIAAAJ, Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health). Its NAICS code is 325412 and its SIC code is 2834.